Nanobiotix S.A. (EPA:NANO)
France flag France · Delayed Price · Currency is EUR
27.40
-1.55 (-5.35%)
Apr 2, 2026, 5:36 PM CET

Nanobiotix Revenue

In the year 2025, Nanobiotix had annual revenue of 32.59M EUR. Nanobiotix had revenue of 5.96M in the half year ending December 31, 2025, a decrease of -81.91%.

Revenue
32.59M
Revenue Growth
n/a
P/S Ratio
40.75
Revenue / Employee
316.44K
Employees
103
Market Cap
1.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.59M39.78M-
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-242.53K-6.52%
Dec 31, 20173.72M-1.70M-31.36%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M2.59M1,398.23%
Dec 31, 2013184.94K-785.67K-80.95%
Dec 31, 2012970.61K-389.71K-28.65%
Dec 31, 20111.36M225.46K19.87%
Dec 31, 20101.13M-1.63M-59.00%
Dec 31, 20092.77M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE174.66M
Cellectis67.79M
Genfit45.13M
MedinCell32.44M
Innate Pharma9.01M
Inventiva7.93M
Transgene7.21M
Sensorion5.81M
Revenue Rankings